分享

口服泼尼松龙治疗急性痛风安全有效

 万宝全书 2016-09-16

作者:Rainer TH

翻译:北医三院 武东(misswudong@163.com)

审校:北医三院 金银姬

摘要  背景:近期2项双盲随机对照研究(RCTs)显示口服激素和非甾体抗炎药对痛风有相似的镇痛效果,但是研究的样本量小,并有其他的方法局限性。

目的:比较口服泼尼松龙与口服消炎痛治疗因急性痛风就诊于急诊(EDs)的患者的有效性和安全性。

设计:多中心,双盲,随机对照研究。患者被随机分为(1:1比例)消炎痛组或泼尼松龙组。(Iclass='imglazyload' srcTN45724113)。部门:香港的4个急诊部。对象:416例18岁以上的患者。测量:镇痛效果被定义为在100mm视觉模拟评分中疼痛改变(静止或活动时)大于13mm。疼痛评分测量在入急诊2小时内,及1到14天进行。

结果:376位患者完成了研究。吲哚美辛组和泼尼松龙组患者表现为相似的疼痛缓解程度,急诊阶段平均疼痛评分大约下降10mm[静息]和20mm[活动],第1到14天时下降约25mm[静息]和45mm[活动]。研究中没有严重不良事件发生。在急诊阶段,吲哚美辛组有更多的轻微副作用(19% VS 6%,P

结论:口服泼尼松龙和消炎痛治疗急性痛风有相似的镇痛效果。泼尼松龙是治疗急性痛风的一种安全,有效的一线药物。

附原文:Abstract BACKGROUND:Two recent double-blind, randomized, controlled trials (RCTs) showed that oral steroids and nonsteroidal anti-inflammatory drugs have similar analgesic effectiveness for management of gout, but the trials had small sample sizes and other methodological limitations.OBJECTIVE:To compare the effectiveness and safety of oral prednisolone versus oral indomethacin in patients presenting to emergency departments (EDs) with acute gout.DESIGN:Multicenter, double-blind, randomized equivalence trial. Patients were randomly assigned (1:1 ratio) to receive either indomethacin or prednisolone. (Iclass='imglazyload' srcTN registry number: Iclass='imglazyload' srcTN45724113).SETTING:Four EDs in Hong Kong.PARTICIPANTS:416 patients aged 18 years or older. MEASUREMENTS:Analgesic effectiveness was defined as changes in pain (at rest or with activity) greater than 13 mm on a 100-mm visual analogue scale. Outcomes were measured during the first 2 hours in the ED and from days 1 to 14.RESULTS:376 patients completed the study. Equivalent and clinically significant within-group reductions in mean pain score were observed with indomethacin and prednisolone in the ED (approximately 10 mm [rest] and 20 mm [activity]) and from days 1 to 14 (approximately 25 mm [rest] and 45 mm [activity]). No major adverse events occurred during the study. During the ED phase, patients in the indomethacin group had more minor adverse events than those in the prednisolone group (19% vs. 6%; P

引自:Rainer TH, Cheng CH, Janssens HJ,et al. Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial. Ann Intern Med. 2016 Apr 5;164(7):464-71.

    本站是提供个人知识管理的网络存储空间,所有内容均由用户发布,不代表本站观点。请注意甄别内容中的联系方式、诱导购买等信息,谨防诈骗。如发现有害或侵权内容,请点击一键举报。
    转藏 分享 献花(0

    0条评论

    发表

    请遵守用户 评论公约

    类似文章 更多